Hailey Newberry , PA
Physician Assistant β’ Clovis, CA
477 W Quincy Ave
Clovis, CA 936194813
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Hailey Newberry is listed in NPPES under Physician Assistant.
-
NPI assigned on May 10, 2023; this date does not establish years in practice.
-
Published CMS data list 360 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Clobetasol Propionate β 78 prescription fills, including refills.
- Ketoconazole β 46 prescription fills, including refills.
- Fluocinonide β 40 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 15 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Physician Assistant in Clovis, CA (2024, 12 clinicians with data). Median for this group: 745. Middle half: 185 to 1,965.
More Part D prescriptions than 60% of clinicians listed under Physician Assistant in California (2024, 7,516 clinicians with data). Median for this group: 229. Middle half: 72 to 718.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
Practice Location & Contact Primary Location
477 W Quincy Ave
Clovis, CA 936194813
CMS Doctors and Clinicians lists 1 group name: Edgar S. Macias, M.D., Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2023
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
391 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$25,825 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,030.28 across 227 records.
By nature of payment
- Food and Beverage: $3,831.94 across 225 records.
- Education: $198.34 across 2 records.
Reporting-company totals (3 largest of 15)
- ABBVIE INC.: $569.98 across 44 records.
- Janssen Pharmaceuticals, Inc: $505.58 across 41 records.
- Incyte Corporation: $417.38 across 17 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
3 years (graduated 2023)
CMS Doctors and Clinicians data list 2023 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2023
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Hailey Newberry has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Hailey Newberry as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Clovis and California
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Physician Assistant in Clovis, CA (2024, 12 clinicians with data). Median for this group: 745. Middle half: 185 to 1,965.
More Part D prescriptions than 60% of clinicians listed under Physician Assistant in California (2024, 7,516 clinicians with data). Median for this group: 229. Middle half: 72 to 718.
Part D drug cost
Close to the middle for clinicians listed under Physician Assistant in Clovis, CA (2024, 12 clinicians with data). Median for this group: $16,144. Middle half: $1,138 to $208,908.
A higher Part D drug cost than 65% of clinicians listed under Physician Assistant in California (2024, 7,516 clinicians with data). Median for this group: $3,945. Middle half: $709 to $60,209.
18 active clinicians are listed under Physician Assistant with a practice address in Clovis, CA (14,458 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Clovis
22.2% of these 18 clinicians have the CMS telehealth indicator.
44.4% of these 18 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
CMS data for Part D prescriptions are available for 2024 only.
-
30-day fills
CMS data for 30-day fills are available for 2024 only.
-
Part D drug cost
CMS data for Part D drug cost are available for 2024 only.
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 114% from $1,882.06 in 2023 to $4,030.28 in 2025.
- 2023: $1,882.06
- 2024: $4,800.16
- 2025: $4,030.28
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 227 records totaling $4,030.28.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
Opzelura | General | $124.97 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $119.12 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $110.27 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $99.99 |
| Regeneron Pharmaceuticals, Inc. |
Education
In-kind items and services
|
DUPIXENT | General | $98.35 |
| Arcutis Biotherapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Zoryve | General | $97.23 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
AKLIEF | General | $78.44 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $48.91 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $41.93 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $39.60 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.55 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.25 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $36.78 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $36.77 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $36.47 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $36.03 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.49 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $34.92 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $34.64 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.87 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.70 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $32.29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Winlevi | General | $32.24 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $31.78 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $31.22 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Clobetasol Propionate | Clobetasol Propionate | 78 | 2,319 | $3,761.72 | 54 |
| Ketoconazole | Ketoconazole | 46 | 1,289 | $932.63 | 34 |
| Fluocinonide | Fluocinonide | 40 | 1,170 | $2,108.90 | 29 |
| Clindamycin Phosphate | Clindamycin Phosphate | 27 | 860 | $1,007.86 | 17 |
| Tacrolimus | Tacrolimus | 23 | 825 | $4,597.07 | 17 |
| Mupirocin | Mupirocin | 22 | 559 | $161.33 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 596 | $330.50 | 13 |
| Hydrocortisone | Hydrocortisone | 18 | 442 | $65.26 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | 420 | $317.16 | β |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 13 | 370 | $929.37 | β |
| Desonide | Desonide | 13 | 415 | $1,164.56 | 11 |
| Nystatin | Nystatin | 12 | 570 | $534.22 | β |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | 360 | $218.48 | β |
| Zoryve | Roflumilast | 12 | 360 | $9,396.04 | β |
| Gentamicin Sulfate | Gentamicin Sulfate | 11 | 438 | $299.60 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-05-10NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PHYSICIAN ASSISTANT
I20231003001276
CA
0244684744
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Edgar S. Macias, M.d., Inc
7115 N Chestnut Ave, Fresno, CA 937200361
Phone: 5594312397
Career & Practice History
NPI enumerated May 10, 2023.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from June 2023 to August 2026.
NPI Administrative Meta
Other Physician Assistants in Clovis
- Tony Reid, PA-C
- Ana Tilghman, PA
- Jonathan Crosby, PA
- Antonieta Acosta, PA-C
- Claire Austin, PA
- Kasey Swafford-Forrest, PA-C
Mailing Address
477 W Quincy Ave
Clovis, CA 936194813